302 related articles for article (PubMed ID: 18212490)
81. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
Cheung DY
Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
[No Abstract] [Full Text] [Related]
82. Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience.
Min GJ; Kang D; Lee HH; Kim SJ; Kim TY; Jeon YW; O JH; Choi BO; Park G; Cho SG
Ann Hematol; 2023 Apr; 102(4):877-888. PubMed ID: 36840791
[TBL] [Abstract][Full Text] [Related]
83. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
[TBL] [Abstract][Full Text] [Related]
84. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
85. [Helicobacter pylori eradication for gastric MALT lymphoma].
Nakamura S; Matsumoto T; Kitazono T
Nihon Rinsho; 2013 Aug; 71(8):1424-8. PubMed ID: 23967674
[TBL] [Abstract][Full Text] [Related]
86. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
[TBL] [Abstract][Full Text] [Related]
87. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
88. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
89. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.
Yeh HZ; Chen GH; Chang WD; Poon SK; Yang SS; Lien HC; Chang CS; Chou G
J Gastroenterol Hepatol; 2003 Feb; 18(2):162-7. PubMed ID: 12542600
[TBL] [Abstract][Full Text] [Related]
90. Bone marrow involvement is not associated with the clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma.
Gong EJ; Ahn JY; Jung HY; Jung K; Cho CJ; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Yoon DH
Scand J Gastroenterol; 2016 Aug; 51(8):942-8. PubMed ID: 27149022
[TBL] [Abstract][Full Text] [Related]
91. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
Roggero E; Zucca E; Pinotti G; Pascarella A; Capella C; Savio A; Pedrinis E; Paterlini A; Venco A; Cavalli F
Ann Intern Med; 1995 May; 122(10):767-9. PubMed ID: 7717599
[TBL] [Abstract][Full Text] [Related]
92. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma.
Ohashi S; Segawa K; Okamura S; Urano H; Kanamori S; Ishikawa H; Hara K; Hukutomi A; Shirai K; Maeda M
Cancer; 2000 May; 88(10):2210-9. PubMed ID: 10820341
[TBL] [Abstract][Full Text] [Related]
93. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.
Park JB; Koo JS
World J Gastroenterol; 2014 Mar; 20(11):2751-9. PubMed ID: 24659867
[TBL] [Abstract][Full Text] [Related]
94. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis.
Zullo A; Hassan C; Andriani A; Cristofari F; De Francesco V; Ierardi E; Tomao S; Morini S; Vaira D
Am J Gastroenterol; 2009 Aug; 104(8):1932-7; quiz 1938. PubMed ID: 19532131
[TBL] [Abstract][Full Text] [Related]
95. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
[TBL] [Abstract][Full Text] [Related]
96. Serological responses of FldA and small-molecular-weight proteins of Helicobacter pylori: correlation with the presence of the gastric MALT tissue.
Yang HB; Sheu BS; Wang JT; Lin ST; Wu JJ
Helicobacter; 2004 Feb; 9(1):81-6. PubMed ID: 15156908
[TBL] [Abstract][Full Text] [Related]
97. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
98. Bone marrow involvement is rare in superficial gastric mucosa-associated lymphoid tissue lymphoma.
Park JY; Kim SG; Kim JS; Jung HC
Dig Liver Dis; 2016 Jan; 48(1):81-6. PubMed ID: 26548745
[TBL] [Abstract][Full Text] [Related]
99. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
100. Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection.
Yoshikane H; Yokoi T; Hidano H; Sakakibara A; Niwa Y; Goto H
J Gastroenterol; 1997 Dec; 32(6):812-6. PubMed ID: 9430022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
